Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Merrimack Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Merrimack Pharmaceuticals Inc market cap is $223.74M.
What is the 52-week high for Merrimack Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Merrimack Pharmaceuticals Inc 52 week high is $15.89 as of September 09, 2025.
What is the 52-week low for Merrimack Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Merrimack Pharmaceuticals Inc 52 week low is $11.53 as of September 09, 2025.
What is Merrimack Pharmaceuticals Inc stock price today?
Merrimack Pharmaceuticals Inc stock price today is $15.13.
What was Merrimack Pharmaceuticals Inc stock price yesterday?
Merrimack Pharmaceuticals Inc stock price yesterday was $15.13.
What is the PE ratio of Merrimack Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Merrimack Pharmaceuticals Inc’s P/E ratio is -8.91.
What is the Price-to-Book ratio of Merrimack Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Merrimack Pharmaceuticals Inc P/B ratio is 0.9920.
What is the 50-day moving average of Merrimack Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Merrimack Pharmaceuticals Inc 50-day moving average is $14.84.